GCIA
ASTX

Gabelli & Co Investment Advisers’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-345,809
Closed -$2.94M – 160
2013
Q3 		$2.94M Buy
+345,809
New +$2.19M 0.64% 40

Gabelli & Co Investment Advisers's ASTX Position: Q4 2013 in Review

Gabelli & Co Investment Advisers sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 345,809 shares — an estimated $2.94M sold.

Gabelli & Co Investment Advisers first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $2.94M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Gabelli & Co Investment Advisers reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 345,809 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $2.94M.
  • Gabelli & Co Investment Advisers first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's ASTEX PHARMACEUTICALS, INC COM position peaked at $2.94M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2013, filed 7 Feb 2014.